Related Experiment Video

Updated: Aug 11, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

The value of an expert system in performing clinical drug trials

W R Dassen1, R Mulleneers, H L Frank

  • 1Department of Cardiology, University of Limburg, Maastricht, The Netherlands.

Computers in Biology and Medicine
|January 1, 1991
PubMed

Insights

An expert system aids cardiologists in clinical trial eligibility decisions. This validated system accurately classifies patients, improving upon physician assessments and optimizing trial entry processes.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Clinical Trial Management

Background:

  • Clinical trial enrollment requires careful adherence to complex inclusion and exclusion criteria.
  • Cardiologists face challenges in efficiently determining patient eligibility for drug trials.

Purpose of the Study:

  • To develop and validate an expert system for assisting cardiologists in patient selection for clinical trials.
  • To assess the accuracy and efficiency of the expert system compared to physician-based classification.

Main Methods:

  • An expert system was designed incorporating knowledge of inclusion/exclusion criteria for six drug trials.
  • The system's performance was validated using 100 randomly selected patients, comparing its classifications to those of a cardiologist.
  • The system's question-ordering algorithm was evaluated for time optimization.

Main Results:

  • The expert system achieved identical classifications to the cardiologist in 97 out of 100 cases.
  • Physician classification errors were identified in three cases where the expert system provided correct eligibility.
  • The system's optimized question order aims to minimize decision-making time.

Conclusions:

  • The developed expert system demonstrates high accuracy and reliability in classifying patients for clinical trials.
  • This tool can enhance the efficiency and precision of clinical trial recruitment in cardiology.
  • The expert system offers a valuable adjunct to cardiologists, potentially reducing errors and speeding up trial participation.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...